These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12887614)

  • 1. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in cows following single dose intravenous administration.
    Varma R; Ahmad AH; Sharma LD; Aggarwal P; Ahuja V
    J Vet Pharmacol Ther; 2003 Aug; 26(4):303-5. PubMed ID: 12887614
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of enrofloxacin and the rate of formation of its metabolite ciprofloxacin following intravenous and intramuscular single dose administration to male buffalo calves.
    Sharma PK; Ahmad AH; Sharma LD; Varma R
    Vet J; 2003 Jul; 166(1):101-4. PubMed ID: 12788024
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin and its interaction with diclofenac after intravenous administration in buffalo calves.
    Kumar N; Singh SD; Jayachandran C
    Vet J; 2003 May; 165(3):302-6. PubMed ID: 12672377
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs.
    Küng K; Riond JL; Wanner M
    J Vet Pharmacol Ther; 1993 Dec; 16(4):462-8. PubMed ID: 8126763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in goats given enrofloxacin alone and in combination with probenecid.
    Rao GS; Ramesh S; Ahmad AH; Tripathi HC; Sharma LD; Malik JK
    Vet J; 2002 Jan; 163(1):85-93. PubMed ID: 11749141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G; Intorre L; Bertini S; Soldani G
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma kinetics and tissue distribution of enrofloxacin and its metabolite ciprofloxacin in the Muscovy duck.
    Intorre L; Mengozzi G; Bertini S; Bagliacca M; Luchetti E; Soldani G
    Vet Res Commun; 1997 Feb; 21(2):127-36. PubMed ID: 9061885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic variables and tissue residues of enrofloxacin and ciprofloxacin in healthy pigs.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Fernández-Cruz ML; Martínez MA; Frejo MT; Martínez M; Iturbe J; Tafur M
    Am J Vet Res; 1999 Nov; 60(11):1377-82. PubMed ID: 10566812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
    Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
    Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of enrofloxacin and tissue concentrations of parent drug and ciprofloxacin after intramuscular administrations of free and liposome-encapsulated enrofloxacin in rabbits.
    Elmas M; Yazar E; Baş AL; Traş B; Bayezit M; Yapar K
    J Vet Med B Infect Dis Vet Public Health; 2002 Dec; 49(10):507-12. PubMed ID: 12485362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows.
    Kaartinen L; Salonen M; Alli L; Pyörälä S
    J Vet Pharmacol Ther; 1995 Oct; 18(5):357-62. PubMed ID: 8587154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of enrofloxacin (Baytril) into the udder after intravenous and intra-arterial injections into dairy cows.
    Malbe M; Salonen M; Fang W; Oöpik T; Jalakas M; Klaassen M; Sandholm M
    Zentralbl Veterinarmed A; 1996 Aug; 43(6):377-86. PubMed ID: 8818302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics after intravenous and oral administration of enrofloxacin in sheep.
    Bermingham EC; Papich MG
    Am J Vet Res; 2002 Jul; 63(7):1012-7. PubMed ID: 12118662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares.
    Papich MG; Van Camp SD; Cole JA; Whitacre MD
    J Vet Pharmacol Ther; 2002 Oct; 25(5):343-50. PubMed ID: 12423224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudate, and bronchial secretions of calves following subcutaneous administration.
    McKellar Q; Gibson I; Monteiro A; Bregante M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1988-92. PubMed ID: 10428924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of baytril (enrofloxacin) in dogs].
    Küng K; Wanner M
    Schweiz Arch Tierheilkd; 1994; 136(10):329-34. PubMed ID: 7801085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
    Kaartinen L; Panu S; Pyörälä S
    Equine Vet J; 1997 Sep; 29(5):378-81. PubMed ID: 9306065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosage regimen of enrofloxacin in buffalo bulls after intramuscular administration.
    Verma HK; Pangawkar GR; Chaudhary RK; Srivastava AK
    Vet Res Commun; 1999 Dec; 23(8):501-5. PubMed ID: 10672966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration of enrofloxacin and its metabolite ciprofloxacin in canine matrices of the locomotor system.
    Ehinger AM; Meyer-Lindenberg A; Vick M; Nolte I; Kietzmann M
    J Vet Med A Physiol Pathol Clin Med; 2002 Mar; 49(2):99-104. PubMed ID: 11958474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
    Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
    J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.